Leaflet TIOTROPIU VIATRIS 18mcg inhalation powder, capsule


Indicated for: asthma; chronic obstructive pulmonary disease

Route of administration: inhalation

Substance: tiotropium (antimuscarinic bronchodilator)

ATC: R03BB04 (Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics)

Tiotropium is a bronchodilator used for the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by blocking muscarinic receptors in the airways, relaxing the muscles and making breathing easier.

The medication is administered via inhaler, usually once daily, as directed by a doctor. It is used for long-term control of symptoms and not for quick relief of breathing crises.

Patients should strictly follow the instructions for using the inhaler and inform their doctor of any unusual symptoms. It is important not to exceed the recommended dose.

Side effects may include dry mouth, cough, throat irritation, and, in rare cases, severe allergic reactions or breathing difficulties. Patients should be informed of these risks before starting treatment.

General data about TIOTROPIU VIATRIS 18mcg

  • Substance: tiotropium
  • Date of last drug list: 01-08-2025
  • Commercial code: W71260001
  • Concentration: 18mcg
  • Pharmaceutical form: inhalation powder, capsule
  • Quantity: 30
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: FERRER INTERNACIONAL, S.A. - SPANIA
  • Holder: VIATRIS LIMITED - IRLANDA
  • Number: 16127/2025/01
  • Shelf life: 2 years

Concentrations available for tiotropium

  • 10mcg
  • 18mcg
  • 2.5mcg

Combinations with other substances